Pharmaron Beijing Co.,Ltd. (300759.SZ) Subsidiary Pharmaron Shaoxing Passes US FDA On-Site Inspection

Stock News

Sep 15

Pharmaron Beijing Co.,Ltd. (300759.SZ) announced that its wholly-owned subsidiary Pharmaron (Shaoxing) Pharmaceutical Co., Ltd. ("Pharmaron Shaoxing") underwent a current Good Manufacturing Practice (cGMP) Pre-Approval Inspection (PAI) conducted by the U.S. Food and Drug Administration (FDA) from May 29 to June 4, 2025. The inspection covered various GMP systems including quality systems, material management systems, production management systems, equipment and facility systems, packaging and labeling systems, and laboratory control systems.

Recently, Pharmaron Shaoxing received the on-site inspection report issued by the U.S. FDA. The inspection report confirmed that Pharmaron Shaoxing's production facilities successfully passed the FDA's on-site quality inspection. According to the inspection report, Pharmaron Shaoxing complies with U.S. pharmaceutical cGMP quality standards and has received FDA certification.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1187192403"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187192403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187192403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-15 18:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187192403","market":"other","top_or_hot":-1,"title":"Pharmaron Beijing Co.,Ltd. (300759.SZ) Subsidiary Pharmaron Shaoxing Passes US FDA On-Site Inspection","media":"Stock News","content":"<p>Pharmaron Beijing Co.,Ltd. (300759.SZ) announced that its wholly-owned subsidiary Pharmaron (Shaoxing) Pharmaceutical Co., Ltd. (\"Pharmaron Shaoxing\") underwent a current Good Manufacturing Practice (cGMP) Pre-Approval Inspection (PAI) conducted by the U.S. Food and Drug Administration (FDA) from May 29 to June 4, 2025. The inspection covered various GMP systems including quality systems, material management systems, production management systems, equipment and facility systems, packaging and labeling systems, and laboratory control systems.</p>\n<p>Recently, Pharmaron Shaoxing received the on-site inspection report issued by the U.S. FDA. The inspection report confirmed that Pharmaron Shaoxing's production facilities successfully passed the FDA's on-site quality inspection. According to the inspection report, Pharmaron Shaoxing complies with U.S. pharmaceutical cGMP quality standards and has received FDA certification.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing Co.,Ltd. (300759.SZ) Subsidiary Pharmaron Shaoxing Passes US FDA On-Site Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing Co.,Ltd. (300759.SZ) Subsidiary Pharmaron Shaoxing Passes US FDA On-Site Inspection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-15 18:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co.,Ltd. (300759.SZ) announced that its wholly-owned subsidiary Pharmaron (Shaoxing) Pharmaceutical Co., Ltd. (\"Pharmaron Shaoxing\") underwent a current Good Manufacturing Practice (cGMP) Pre-Approval Inspection (PAI) conducted by the U.S. Food and Drug Administration (FDA) from May 29 to June 4, 2025. The inspection covered various GMP systems including quality systems, material management systems, production management systems, equipment and facility systems, packaging and labeling systems, and laboratory control systems.</p>\n<p>Recently, Pharmaron Shaoxing received the on-site inspection report issued by the U.S. FDA. The inspection report confirmed that Pharmaron Shaoxing's production facilities successfully passed the FDA's on-site quality inspection. According to the inspection report, Pharmaron Shaoxing complies with U.S. pharmaceutical cGMP quality standards and has received FDA certification.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1187192403","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187192403","pubTimestamp":1757932818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Pharmaron Beijing Co.,Ltd. (300759.SZ) announced that its wholly-owned subsidiary Pharmaron (Shaoxing) Pharmaceutical Co., Ltd. (\"Pharmaron Shaoxing\") underwent a current Good Manufacturing Practice...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","03759":"康龙化成","BK0216":"研究试验"},"translate_title":"康龙化成（北京）有限公司。(300759.SZ)子公司康龙化成绍兴通过美国FDA现场检查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1},"content_text":"Pharmaron Beijing Co.,Ltd. (300759.SZ) announced that its wholly-owned subsidiary Pharmaron (Shaoxing) Pharmaceutical Co., Ltd. (\"Pharmaron Shaoxing\") underwent a current Good Manufacturing Practice (cGMP) Pre-Approval Inspection (PAI) conducted by the U.S. Food and Drug Administration (FDA) from May 29 to June 4, 2025. The inspection covered various GMP systems including quality systems, material management systems, production management systems, equipment and facility systems, packaging and labeling systems, and laboratory control systems.\nRecently, Pharmaron Shaoxing received the on-site inspection report issued by the U.S. FDA. The inspection report confirmed that Pharmaron Shaoxing's production facilities successfully passed the FDA's on-site quality inspection. According to the inspection report, Pharmaron Shaoxing complies with U.S. pharmaceutical cGMP quality standards and has received FDA certification.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}